HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

No interplay between the pathways mediating coagulation and inflammation in tissue factor-induced disseminated intravascular coagulation in rats.

AbstractOBJECTIVE:
Previous reports have suggested an interplay between the pathways mediating coagulation and inflammation in endotoxemia and sepsis. The present study was designed to examine whether cross-signaling between the pathways mediating coagulation and inflammation occurs, as suggested by the pattern of cytokine production observed following tissue-factor (TF)-induced disseminated intravascular coagulation (DIC).
DESIGN:
Prospective, comparative, experimental study.
SETTING:
Laboratory at a university hospital.
SUBJECTS:
Male Wistar rats, aged 6-7 wks, and weighing 160-170 g.
INTERVENTIONS:
Male Wistar rats were administered TF (3.75 units/kg every 4 hrs), TF, and tranexamic acid (TA; 50 mg/kg every 4.5 hrs) or lipopolysaccharide (30 mg/kg every 4 hrs) via the tail vein, and blood was sampled at 0, 4, 8 and 12 hrs.
MEASUREMENTS AND MAIN RESULTS:
Subsequent alterations in thrombin-antithrombin complex and fibrinogen levels, as well as platelet counts, indicated that the severity of both types of experimental DIC (TF-induced and lipopolysaccharide-induced) was similar with respect to hemostatic activation and development of consumption coagulopathy. In lipopolysaccharide-induced DIC, a sharp increase in plasma tumor necrosis factor levels was observed at 4 hrs, after which a sharp decline was noted. Plasma levels of interleukin-6 were markedly increased at 4 hrs, after which a sustained elevation was observed for the duration of the experimental period (tumor necrosis factor, 1270 +/- 280, 180 +/- 40, and 120 +/- 30 pg/mL at 4, 8 and 12 hrs, respectively; interleukin-6, 5810 +/- 1320, 4850 +/- 730, and 5230 +/- 1280 pg/mL at 4, 8 and 12 hrs, respectively). On the other hand, tumor necrosis factor and interleukin-6 were not detected following TF-induced DIC (0 +/- 0 at 4, 8, and 12 hrs for both tumor necrosis factor and interleukin-6). In the TF+TA group, significant increases in tumor necrosis factor and interleukin-6 were observed, compared with the TF group.
CONCLUSIONS:
There is no overt interplay between the pathways mediating coagulation and inflammation in TF-induced DIC, as observed in lipopolysaccharide-induced DIC.
AuthorsYasuo Ontachi, Hidesaku Asakura, Yoko Takahashi, Tomoe Hayashi, Masahisa Arahata, Yasuko Kadohira, Mio Maekawa, Mika Omote, Tomotaka Yoshida, Masahide Yamazaki, Eriko Morishita, Ken-ichi Miyamoto, Shinji Nakao
JournalCritical care medicine (Crit Care Med) Vol. 34 Issue 10 Pg. 2646-50 (Oct 2006) ISSN: 0090-3493 [Print] United States
PMID16932226 (Publication Type: Comparative Study, Evaluation Study, Journal Article)
Chemical References
  • Antifibrinolytic Agents
  • Cytokines
  • Hemostatics
  • Interleukin-6
  • Lipopolysaccharides
  • Tumor Necrosis Factor-alpha
  • Interleukin-10
  • Tranexamic Acid
  • Thromboplastin
Topics
  • Animals
  • Antifibrinolytic Agents (pharmacology)
  • Cytokines (drug effects, metabolism)
  • Disseminated Intravascular Coagulation (chemically induced, physiopathology)
  • Hemostatics (pharmacology)
  • Interleukin-10 (metabolism)
  • Interleukin-6 (metabolism)
  • Lipopolysaccharides (pharmacology)
  • Male
  • Prospective Studies
  • Rats
  • Rats, Wistar
  • Receptor Cross-Talk (drug effects)
  • Signal Transduction (drug effects)
  • Thromboplastin (pharmacology)
  • Tranexamic Acid (pharmacology)
  • Tumor Necrosis Factor-alpha (metabolism)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: